SHARE
COPY LINK

COVID-19

Norway health agency wants people with even mild symptoms to get tested

Norway's health authorities have called for everyone with any potential coronavirus symptoms, even a slight cough or sore throat, to try to get tested for the virus.

Norway health agency wants people with even mild symptoms to get tested
Espen Nakstad said that it was important to maintain high testing capacity even if it is not being used. Photo: Finn Oluf Nyquist/Directorate of Health
“It is important to know what the current advice is so that you do not pass on the infection to others,” Line Vold, from the Norwegian Institute of Public Health told state broadcaster NRK
 
“Testing is part of the system we have for monitoring the epidemic. It is important that everyone gets tested in order to be able to keep on top of the infection rate going forward.” 
 
While Norway has built up the capacity to test over 100,000 people a week, it is currently testing a fraction of that, with just 14,593 tested last week. 
 
“Right now, few people have respiratory tract infections, so there are only a few people who need to take the test, compared to what there would be in a season where more people get respiratory infection, which we expect to be the case this autumn,” Vold said.
 
Espen Rostrup Nakstad, acting deputy director at Norway's Directorate of Health, said that Norway could easily increase its testing capacity well beyond 100,000 if necessary. 
 
“We are determined that the capacity should be high, so that if we get into a situation with a lot of contagion, we will be able to test as many people as possible who have symptoms,” he said. 
 
 
Nakstad said that health authorities were currently working on a saliva test which would be easier to carry out than current throat and nose swab tests, and potentially require fewer testing personnel. 
 
To get a test, he said, people should check the website of their local municipality and find out how and where to take a test locally. 
 
In Oslo, for instance, you should ring your doctor, or ring the municipality's 'koronatelefonen' on 21802182. 
 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Public Health Agency recommends two Covid doses next year for elderly

Sweden's Public Health Agency is recommending that those above the age of 80 should receive two doses of a Covid-19 vaccine a year, once in the spring and once in the autumn, as it shifts towards a longer-term strategy for the virus.

Public Health Agency recommends two Covid doses next year for elderly

In a new recommendation, the agency said that those living in elderly care centres, and those above the age of 80 should from March 1st receive two vaccinations a year, with a six month gap between doses. 

“Elderly people develop a somewhat worse immune defence after vaccination and immunity wanes faster than among young and healthy people,” the agency said. “That means that elderly people have a greater need of booster doses than younger ones. The Swedish Public Health Agency considers, based on the current knowledge, that it will be important even going into the future to have booster doses for the elderly and people in risk groups.” 

READ ALSO: 

People between the ages of 65 and 79 years old and young people with risk factors, such as obesity, diabetes, poor kidney function or high blood pressure, are recommended to take one additional dose per year.

The new vaccination recommendation, which will start to apply from March 1st next year, is only for 2023, Johanna Rubin, the investigator in the agency’s vaccination programme unit, explained. 

She said too much was still unclear about how long protection from vaccination lasted to institute a permanent programme.

“This recommendation applies to 2023. There is not really an abundance of data on how long protection lasts after a booster dose, of course, but this is what we can say for now,” she told the TT newswire. 

It was likely, however, that elderly people would end up being given an annual dose to protect them from any new variants, as has long been the case with influenza.

SHOW COMMENTS